Information
3F, 28 Simin-daero 327beon-gil, Dongan-gu, Anyang, Gyeonggi-do, South Korea
+82 31604277
-
Overview
- Summary
- A company developing innovative products based on bio-convergence technology. Possessing life science product lines such as automated cell counters, digital imaging systems, and tissue clearing systems. Driving the development and commercialization of the GeneScale product line, an on-site molecular diagnostic solution. A specialized enterprise supplying advanced equipment and reagents for global life science research and diagnostics.A company developing innovative products based on bio-convergence technology. Possessing life science product lines such as automated cell counters, digital imaging systems, and tissue clearing systems. Driving the development and commercialization of the GeneScale product line, an on-site molecular diagnostic solution. A specialized enterprise supplying advanced equipment and reagents for global life science research and diagnostics.
- Key Products/Technologies
- Development and supply of LUNA™ series automated cell counters (LUNA™, LUNA-II™, LUNA-FX7™).Development and supply of LUNA™ series automated cell counters (LUNA™, LUNA-II™, LUNA-FX7™).
- Provision of LUNA-FL™ and LUNA-STEM™ automated fluorescence cell counters (dedicated for stem cells and SVF).Provision of LUNA-FL™ and LUNA-STEM™ automated fluorescence cell counters (dedicated for stem cells and SVF).
- Possession of life science research equipment including digital imaging systems and tissue clearing systems.Possession of life science research equipment including digital imaging systems and tissue clearing systems.
- Application of QUANTOM Tx™ microbial cell counter for automatic detection and analysis of microorganisms such as bacteria.Application of QUANTOM Tx™ microbial cell counter for automatic detection and analysis of microorganisms such as bacteria.
- Development of ultra-compact point-of-care molecular diagnostic solutions based on GeneScale Technology.Development of ultra-compact point-of-care molecular diagnostic solutions based on GeneScale Technology.
- Technological capability to automatically perform all processes from nucleic acid extraction to gene detection within an ultra-compact cartridge.Technological capability to automatically perform all processes from nucleic acid extraction to gene detection within an ultra-compact cartridge.
- Possession of analyte collection device and sample processing cartridge technology (utilizing magnetic particles, miniaturization, automated sample processing).Possession of analyte collection device and sample processing cartridge technology (utilizing magnetic particles, miniaturization, automated sample processing).
- Automated sample purification, amplification, and detection for PCR diagnostics, with applicability to various bio-derived samples like blood, saliva, and urine.Automated sample purification, amplification, and detection for PCR diagnostics, with applicability to various bio-derived samples like blood, saliva, and urine.
- Core Advantages
- World-class convergence technology covering broad fields such as bio, optics, electrical/electronics, software, and clinical applications.World-class convergence technology covering broad fields such as bio, optics, electrical/electronics, software, and clinical applications.
- Capability in developing, manufacturing, and globally selling advanced equipment and reagents for life science research and diagnostics.Capability in developing, manufacturing, and globally selling advanced equipment and reagents for life science research and diagnostics.
- Technological validation through 10 years of accumulated technology from its predecessor Logos Biosystems and over 5,000 international academic paper citations.Technological validation through 10 years of accumulated technology from its predecessor Logos Biosystems and over 5,000 international academic paper citations.
- Proactive market penetration in POCT and on-site molecular diagnostics with the GeneScale™ product line.Proactive market penetration in POCT and on-site molecular diagnostics with the GeneScale™ product line.
- Securing global intellectual property rights through US patent acquisition for core molecular diagnostic technologies like the analyte collection device.Securing global intellectual property rights through US patent acquisition for core molecular diagnostic technologies like the analyte collection device.
- Application of LUNA-FX7™ automated cell counters in GMP production facilities and full compliance with 21 CFR Part 11 electronic document requirements.Application of LUNA-FX7™ automated cell counters in GMP production facilities and full compliance with 21 CFR Part 11 electronic document requirements.
- Competitive advantage in manufacturing reliability and cost reduction through the simple structure and automated production process of molecular diagnostic cartridges.Competitive advantage in manufacturing reliability and cost reduction through the simple structure and automated production process of molecular diagnostic cartridges.
- Establishment of global partnerships for market expansion in Asia, including China and Japan, and operation of overseas branches in the US and France.Establishment of global partnerships for market expansion in Asia, including China and Japan, and operation of overseas branches in the US and France.
- Target Industrie
- Life science research and diagnostics.Life science research and diagnostics.
- Research, development, and production processes in the bio and pharmaceutical industries.Research, development, and production processes in the bio and pharmaceutical industries.
- Clinical research and cell therapy manufacturing (CAR-T cell therapy, stem cell-based therapies).Clinical research and cell therapy manufacturing (CAR-T cell therapy, stem cell-based therapies).
- Point-of-care diagnostic solutions for infectious diseases, chronic diseases, and personalized diagnostics.Point-of-care diagnostic solutions for infectious diseases, chronic diseases, and personalized diagnostics.
- Business expansion into the companion animal and livestock diagnostics market.Business expansion into the companion animal and livestock diagnostics market.
- Major Markets
- Entry into the Chinese market and OEM contract with Shanghai Tech., Expansion into Southeast Asian markets including Thailand and Vietnam., Strengthening market presence through the establishment of a Japanese branch., Supply of products to Taiwanese cell therapy companies and plans for market expansion in other Asian regions like Singapore.Entry into the Chinese market and OEM contract with Shanghai Tech., Expansion into Southeast Asian markets including Thailand and Vietnam., Strengthening market presence through the establishment of a Japanese branch., Supply of products to Taiwanese cell therapy companies and plans for market expansion in other Asian regions like Singapore.
- Operation of an overseas branch in France., Supply of products to European pharmaceutical company Mikrobiomik.Operation of an overseas branch in France., Supply of products to European pharmaceutical company Mikrobiomik.
- Operation of an overseas branch in Washington D.C., USA., Acquisition of US patents related to analyte collection devices., Supply of products to major US pharmaceutical companies including Vertex Pharmaceuticals and Moderna.Operation of an overseas branch in Washington D.C., USA., Acquisition of US patents related to analyte collection devices., Supply of products to major US pharmaceutical companies including Vertex Pharmaceuticals and Moderna.
- Certifications/Patents
- Acquisition of a US patent (USPTO) for an analyte collection device (Application No. 17/440106).Acquisition of a US patent (USPTO) for an analyte collection device (Application No. 17/440106).
- Awarded the Commissioner of the Korean Intellectual Property Office Prize at the 2024 Korea Intellectual Property Exhibition for microbial detection and analysis technology.Awarded the Commissioner of the Korean Intellectual Property Office Prize at the 2024 Korea Intellectual Property Exhibition for microbial detection and analysis technology.
- Securing technology-based competitiveness through the possession of over 60 patents.Securing technology-based competitiveness through the possession of over 60 patents.
- Acquisition of GMP certification for the full-scale mass production system preparation of GeneScale™ products.Acquisition of GMP certification for the full-scale mass production system preparation of GeneScale™ products.
- Designation of QUANTOM Tx™ microbial cell counter as an innovative product by the Ministry of SMEs and Startups.Designation of QUANTOM Tx™ microbial cell counter as an innovative product by the Ministry of SMEs and Startups.
- Full integration of 21 CFR Part 11 electronic document requirements for LUNA-FX7™, providing data integrity, automatic storage, electronic signatures, and audit trail functions.Full integration of 21 CFR Part 11 electronic document requirements for LUNA-FX7™, providing data integrity, automatic storage, electronic signatures, and audit trail functions.
Introduction
Location
3F, 28 Simin-daero 327beon-gil, Dongan-gu, Anyang, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
